In summary, nine gene signatures (CYFIP2, HOXB5, EGFR, FOXN3, PTPN3, CDC20, MARCKSL1, FAS, and PTCH1) may play central roles in the initiation and progression of BCC, which provides deeper insights into BCC management. This evidence concerns the gene CYFIP2 and skin basal cell carcinoma.